Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01457053 · ClinicalTrials.gov registry record · NA
Assessment of Coronary Flow Reserve in Heart Failure Patients After Ultrafiltration Versus Diuretics
A NA study, sponsored by University of Cincinnati.
- Terminated
- Registry status
- NA
- Development phase
- 4
- Enrollment target
NCT01457053 is a NA study that was terminated before completion, run by University of Cincinnati. The registered enrollment target is 4 participants.
The verdict
NCT01457053, a NA study, was terminated before completion, sponsored by University of Cincinnati.
- TERMINATED
- Registry status
- NA
- Development phase
- 4 participants
- Enrollment target
Study Summary
The purpose of this research study is to compare the effects (good and bad) of ultrafiltration treatment with standard intravenous (in your vein) diuretic therapy (furosemide, torsemide, bumetanide) on your heart function and blood flow.
Interventions
- OTHER Ultrafiltration
- DRUG Loop diuretics (furosemide, torsemide, bumetanide)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4 participants |
| Start Date | 2011-11 |
| Est. Completion | 2013-05 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01457053
The ClinicalTrials.gov registry entry for NCT01457053 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 4 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Cincinnati, which has 245 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Ultrafiltration is the first listed.
NCT01457053 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01457053 about?
NCT01457053 is a clinical study titled "Assessment of Coronary Flow Reserve in Heart Failure Patients After Ultrafiltration Versus Diuretics". The purpose of this research study is to compare the effects (good and bad) of ultrafiltration treatment with standard intravenous (in your vein) diuretic therapy (furosemide, torsemide, bumetanide) on your heart function and blood flow.
What is the current status of trial NCT01457053?
This trial is currently terminated. It is a NA study. The enrollment target is 4 participants. The study started on 2011-11. Estimated completion is 2013-05.
What interventions are being tested in trial NCT01457053?
The interventions under investigation include: Ultrafiltration (OTHER), Loop diuretics (furosemide, torsemide, bumetanide) (DRUG).
Who is sponsoring clinical trial NCT01457053?
This trial is sponsored by University of Cincinnati, which has 245 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.